|
King Pharmaceuticals might not rule the drug market, but it doesn't mind taking the reigns over on certain products under development. The company is engaged in marketing pain management drugs and developing later-stage pharmaceutical candidates in the areas of neuroscience and acute care. Already it has a portfolio of branded prescription products, including chronic pain drug Avinza, muscle relaxant Skelaxin, and blood-loss control aid Thrombin-JMI. It also produces emergency drug delivery devices through subsidiary Meridian Medical Technologies and medicated feed additives through Alpharma Animal Health; King acquired rival Alpharma for $1.6 billion in late 2008.
|
| | | Contact Information | |
Address: |
501 5th St.
Bristol, TN 37620
| | Phone: | 423-989-8000 | | Fax: | 423-274-8677 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 1565.10 M | | Revenue Growth (1 yr): | (-26.80%) | | Employees (2008): | 3,392 | | Employee Growth (1 yr): | 65.30% |
|
|
Key People
| | • |
Chairman, President, and CEO:
Brian A. Markison
| | • |
CFO:
Joseph Squicciarino
| | • |
EVP Technical Operations:
Bradley Knoll
|
|
|
